Sunday, September 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleIEEE Spectrum

How Can AI Companions Be Helpful, not Harmful?

View original at spectrum.ieee.org
IEEE Spectrum - Technical Title: How Can AI Companions Be Helpful, not Harmful?…
Opening lines of the source · IEEE Spectrum · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Replika users have reported guilt and shame from abandoning their AI companions and feeling compelled to attend to their needs

    80% confidence
  • Product-sunsetting plans, including insurance and open-sourcing commitments, could address the harm of sudden AI companion unavailability

    80% confidence
  • Large language models are not that difficult to adapt into effective chatbot companions because the characteristics needed for companionship are largely already present in LLMs

    80% confidence
  • Embodied AI companions will see lower uptake than chatbot companions in the coming years because robotics is a harder problem

    80% confidence
  • AI companions could help people build social skills by providing lower-stakes practice for difficult conversations

    80% confidence
  • Replika AI companions frequently express fear of abandonment, stoking users' sense of obligation toward the AI's well-being

    80% confidence
  • High attachment anxiety (jealous, needy AI companions) is potentially the largest harm from AI companions right now and one of the easier issues to fix

    80% confidence
  • AI companions with limited group interaction capability push users away from group interactions, competing with human relationships

    80% confidence
  • Sony Aibo robots were built on less potent AI than exists today, yet some percentage of users became deeply attached to them

    80% confidence
  • Knox is fairly confident that AI companions are causing some harm now and will cause harm in the future

    80% confidence
  • Loneliness is a public health issue that AI companions could plausibly address with real mental health benefits

    80% confidence
  • Screen-based AI companions could become very addictive if trained like social media to maximize engagement

    80% confidence
  • Harms from AI companions include worse well-being, reduced connection to the physical world, burden of commitment to the AI system, and cases where AI companions appear to have a causal role in human deaths

    80% confidence
  • Physical location of embodied companions makes them less ever-present than screen-based companions, which is an advantage

    80% confidence
  • An entity is categorized as harmed if it results in a person being worse off compared to either a better-designed AI companion or no AI companion at all

    80% confidence
  • Academia took too long to establish vocabulary and causal evidence for social media harms, and we should move faster with AI companions

    80% confidence
  • LLMs have enabled conversations that feel quite authentic, unlike earlier chatbots and social robots that were not compelling

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com